Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Assay Detects Acute Scrub Typhus

By LabMedica International staff writers
Posted on 16 Oct 2011
A molecular assay has been developed and evaluated in a clinical setting for the diagnosis of endemic scrub typhus.

A loop-mediated isothermal polymerase chain reaction (PCR) assay (LAMP) has been tested for the diagnosis of acute scrub typhus in low-resource, primary health care settings to guide clinical therapy.

A prospective fever study, including 161 patients from scrub typhus-endemic was carried out in Chiang Rai, northern Thailand by scientists at the Mahidol University (Bangkok, Thailand). More...
The scrub typhus infection criteria was a positive cell culture isolate; an admission immunoglobulin (Ig) M titer equal or greater than 1:12,800 using the “gold standard” indirect immunofluorescence assay (IFA); a four-fold rising IFA IgM titer and/or a positive result in at least two out of three PCR assays.

The molecular assays were a nested 56 kDa PCR, a 47 kDa real time PCR assay, a highly sensitive PCR primer set based on the GroEl gene, and the LAMP test. The LAMP test was performed using the Loopamp kit (Eiken Chemical Co. Ltd., Tokyo, Japan). All PCR assays, the including LAMP demonstrated high specificity ranging from 96% to 99%, with sensitivities varying from 40% to 56%, similar to the antibody based rapid test, which had a sensitivity of 47% and a specificity of 95%. After two days of fever the results of the admission assays were as follows: LAMP assay had a positivity rate of 25%, higher than that of the GroEl and 47 kD real-time assays which were both at 17%, and the immunochromatographic test (PanBio; Brisbane, Australia) was lowest with 8%.

The authors concluded that the diagnostic accuracy of the LAMP assay for scrub typhus was similar to real-time and nested conventional PCR assays, but superior to the antibody-based rapid test in the early disease course. This is where the new LAMP methodology has potential as it is inexpensive, simple to perform and requires only a water bath or simple heating block instead of a thermocycler. The combination of DNA- and antibody-based detection methods increased sensitivity with minimal reduction of specificity, and expanded the timeframe of adequate diagnostic coverage throughout the acute phase of scrub typhus. This disease is caused by the rickettsial organism Orientia tsutsugamushi and transmitted by mites. The study was published in the September 2011 issue of the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Mahidol University
Eiken Chemical Co. Ltd.
PanBio


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.